retatrutide alternative Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide vs Ozempic: Triple-Action |
Description
Absolute contraindications to GLP-1 receptor agonists include: Personal history of medullary thyroid carcinoma Family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Pregnancy (for weight management indications) Severe gastrointestinal disease, including gastroparesis Patients should be specifically questioned about these conditions during pre-treatment evaluation

While metabolic/bariatric surgeons had long recognized these beneficial attributes following metabolic/bariatric surgery, the discovery that these agents could result in similar health benefits was a revelation to many clinicians

Limitations Our study, while providing valuable insights into the weight loss-independent effects of low-dose semaglutide in a preclinical HFpEF model, has several limitations that warrant consideration
"*" indicates required fields
In the same press release, she added, GLP-1 users face specific nutritional challenges and finding products tailored to these needs can be challenging

No default dosing
